Fundz

Synedgen Receives Supplemental NEI Funding to Identify Lead Development Candidate for Ocular Mustard Gas Injury Program

PRIVATEOct 29, 2020

Round Type

Funding Round

ClaremontHealthcareHealth Care

Description

Synedgen, a biotechnology company using glycopolymer chemistry to develop drugs that enhance and control signaling in the innate immune system, today announced supplemental funding from the National Eye Institute (NEI) of the NIH to identify a lead molecule from the company’s ocular mustard gas injury program to move into animal studies.

Quick answer

Synedgen raised an undisclosed amount in a Funding Round round, dated October 29, 2020. Synedgen is based in Claremont, California, United States.

How much did Synedgen raise?
Synedgen raised an undisclosed amount in a Funding Round round on October 29, 2020.
What does Synedgen do?
Synedgen, Inc. is a biotechnology company developing Multivalent Innate Immune Signaling Target (MIIST) therapeutics that modulate and enhance the innate immune system.
Where is Synedgen based and how big is it?
Synedgen is based in Claremont, California, United States. Fundz records about 20 employees.
Who are the decision-makers at Synedgen?
Fundz holds 1 contact at Synedgen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Synedgen that raised within 45 days of this round, from Fundz verified event records.

  • Bluejay Diagnostics raised $154K on December 10, 2020.
  • Preceptis Medical raised $3.2M (Seed) on December 10, 2020.
  • Actuate Therapeutics raised $14M on December 10, 2020.
  • Kinaset Therapeutics raised $40M (Series A) on November 30, 2020.
  • Azora Therapeutics, Inc. (DE) raised $296K on November 30, 2020.
  • Reliq Health Technologies raised $495K (Seed) on November 27, 2020.

Who to call at Synedgen, and when

A new round usually means Synedgen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Synedgen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Synedgen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Synedgen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Synedgen

Location

1420 N. CLAREMONT BOULEVARD

Claremont, California, United States

About

Synedgen, Inc. is a biotechnology company developing Multivalent Innate Immune Signaling Target (MIIST) therapeutics that modulate and enhance the innate immune system. The company’s lead development candidate is MIIST305, an oral, glycocalyx targeted induction and maintenance therapy for ulcerative colitis (UC). With US Government support, MIIST305 is also being developed in parallel as a medical countermeasure (MCM) for gastrointestinal acute radiation syndrome (GI-ARS). MIIST technology has been validated with clinical trials in partnered programs and extensively peer-reviewed through twenty-two (22) National Institutes of Health grants and Department of Defense contracts. Synedgen has an in-house GMP manufacturing facility.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Synedgen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts14 people are listed at Synedgen. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Synedgen's next move

See what Strategic adds

Synedgen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.